Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 25, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	490	497	611	312	385	263	Upgrade
Market Cap Growth	-18.74%	-18.74%	95.74%	-18.80%	46.51%	36.51%	Upgrade
Enterprise Value	486	-382	-219	-605	-523	-540	Upgrade
Last Close Price	46.75	47.40	57.12	29.18	34.70	22.85	Upgrade
PE Ratio	40.30	40.83	4.97	52.03	6.23	2.75	Upgrade
PS Ratio	17.28	17.52	3.51	16.56	5.26	2.26	Upgrade
PB Ratio	0.45	0.46	0.56	0.32	0.39	0.28	Upgrade
P/TBV Ratio	0.45	0.46	0.56	0.32	0.39	0.28	Upgrade
P/FCF Ratio	-	-	-	-	100.21	-	Upgrade
P/OCF Ratio	453.32	459.62	-	-	100.21	-	Upgrade
EV/Sales Ratio	17.15	-	-	-	-	-	Upgrade
EV/EBITDA Ratio	32.75	-	-	-	-	-	Upgrade
EV/EBIT Ratio	35.00	-	-	-	-	-	Upgrade
EV/FCF Ratio	-55.12	-	-	-	-	-	Upgrade
Asset Turnover	0.03	0.03	0.16	0.02	0.07	0.13	Upgrade
Quick Ratio	0.13	0.13	17.24	19.75	21.59	31.03	Upgrade
Current Ratio	21.97	21.97	17.29	19.82	21.66	31.15	Upgrade
Return on Equity (ROE)	1.11%	1.11%	11.87%	0.61%	6.45%	10.76%	Upgrade
Return on Assets (ROA)	0.76%	0.76%	9.29%	0.57%	4.94%	7.59%	Upgrade
Return on Capital (ROIC)	0.79%	0.79%	9.73%	0.60%	5.14%	7.79%	Upgrade
Return on Capital Employed (ROCE)	1.30%	1.30%	14.70%	1.00%	8.00%	11.80%	Upgrade
Earnings Yield	2.48%	2.45%	20.10%	1.92%	16.05%	36.34%	Upgrade
FCF Yield	-1.80%	-1.78%	-3.74%	-0.33%	1.00%	-4.39%	Upgrade
Dividend Yield	3.91%	-	3.15%	-	3.46%	6.56%	Upgrade
Payout Ratio	155.05%	155.05%	-	209.50%	25.46%	-	Upgrade
Buyback Yield / Dilution	-0.08%	-0.08%	-	0.00%	0.00%	-	Upgrade
Total Shareholder Return	3.87%	-0.08%	3.15%	0.00%	3.46%	6.56%	Upgrade

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.